| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 51.113 | 53.869 | 58.014 | 71.561 | 80.285 | 59.412 | 89.124 | 98.989 | 103.276 | 110.661 |
| Total Income - EUR | 51.113 | 53.872 | 58.014 | 71.561 | 80.259 | 60.104 | 90.934 | 99.003 | 103.276 | 110.775 |
| Total Expenses - EUR | 49.162 | 52.843 | 56.617 | 70.469 | 79.053 | 53.452 | 78.596 | 87.939 | 91.525 | 99.067 |
| Gross Profit/Loss - EUR | 1.952 | 1.029 | 1.396 | 1.092 | 1.206 | 6.652 | 12.338 | 11.064 | 11.752 | 11.707 |
| Net Profit/Loss - EUR | 418 | 490 | 286 | 376 | 445 | 6.250 | 11.464 | 10.074 | 10.719 | 10.097 |
| Employees | 2 | 2 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Mediralex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.594 | -202 | -198 | 0 | 0 | 0 | 17.667 | 17.722 | 17.668 | 17.570 |
| Current Assets | 17.557 | 19.329 | 25.635 | 25.508 | 27.994 | 34.792 | 38.241 | 41.316 | 39.648 | 35.979 |
| Inventories | 16.130 | 18.240 | 24.530 | 25.200 | 27.661 | 31.131 | 36.320 | 39.863 | 38.949 | 34.953 |
| Receivables | 782 | 477 | 985 | 164 | 161 | 1.368 | 381 | 155 | 154 | 338 |
| Cash | 645 | 611 | 120 | 144 | 172 | 2.293 | 1.540 | 1.299 | 545 | 688 |
| Shareholders Funds | 9.642 | 2.517 | 2.760 | 3.086 | 3.472 | 8.415 | 11.606 | 11.577 | 21.382 | 24.148 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 15.509 | 16.610 | 22.676 | 22.851 | 25.786 | 26.377 | 44.302 | 47.461 | 35.935 | 29.400 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4719 - 4719" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Mediralex Srl